Showing results (2011-2020 of 2,234) with videos related to

Sort By:
Pageof 224
Cancer Biotherapy & Radiopharmaceuticals|January 11, 2019
A Study on the Correlations of the miR-31 Expression with the Pathogenesis and Prognosis of Head and Neck Squamous Cell CarcinomaHualong Qiang, Xiaodong Zhan, Wei Wang, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 2, 2019
The Role of miRNA in the Diagnosis, Prognosis, and Treatment of OsteosarcomaJicheng Wang, Shizhang Liu, Jiyuan Shi, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 10, 2020
Knockdown of NRAGE Impairs Homologous Recombination Repair and Sensitizes Hepatoblastoma Cells to Ionizing RadiationLi Liu, Zhongqi Cui, Jie Zhang, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 7, 2019
In Vitro Characterization of a Potent p53-MDM2 Inhibitor, RG7112 in Neuroblastoma Cancer Cell LinesAbdulhameed Al-Ghabkari, Aru Narendran
Cancer Biotherapy & Radiopharmaceuticals|December 27, 2018
Adenovirus-Mediated CRM197 Sensitizes Human Glioma Cells to Gemcitabine by the Mitochondrial PathwayLv-Xia Dai, Jing Yang, Jian-Min Liu, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 7, 2020
LncRNA FENDRR Upregulation Promotes Hepatic Carcinoma Cells Apoptosis by Targeting miR-362-5p Via NPR3 and p38-MAPK PathwayGuangyu Qian, Xiaoyan Jin, Louwei Zhang
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2020
Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing MiceWioletta Wojdowska, Urszula Karczmarczyk, Lajos Balog, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 25, 2019
Imaging of HER2 with [89Zr]pertuzumab in Response to T-DM1 TherapyAdriana V F Massicano, Supum Lee, Bryant K Crenshaw, et al.
Pageof 224